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The regulation of skeletal muscle mass depends on the balance between protein
synthesis and degradation. The role of protein degradation and in particular, the ubiquitin
proteasome system, and increased expression of the E3 ubiquitin ligases, MuRF1 and
MAFbx/atrogin-1, in the regulation of muscle size in response to growth stimuli is unclear.
Thus, the aim of this study was to measure both proteasome activity and protein
synthesis in mice over a 14-day period of chronic loading using the functional overload
(FO) model. Further, the importance of MuRF1 andMAFbx expression in regulating muscle
hypertrophy was examined by measuring muscle growth in response to FO in mice with
a null deletion (KO) of either MuRF1 or MAFbx. In wild type (WT) mice, the increase in
muscle mass correlated with significant increases (2-fold) in protein synthesis at 7 and 14
days. Interestingly, proteasome activity significantly increased in WT mice after one day,
and continued to increase, peaking at 7 days following FO. The increase in proteasome
activity was correlated with increases in the expression of the Forkhead transcription
factors, FOXO1 and FOXO3a, which increased after both MuRF1 and MAFbx increased
and returned to baseline. As in WT mice, hypertrophy in the MuRF1 and MAFbx KO mice
was associated with significant increases in proteasome activity after 14 days of FO. The
increase in plantaris mass was similar between the WT and MuRF1 KOmice following FO,
however, muscle growth was significantly reduced in female MAFbx KOmice. Collectively,
these results indicate that muscle hypertrophy is associated with increases in both protein
synthesis and degradation. Further, MuRF1 or MAFbx expression is not required to
increase proteasome activity following increased loading, however, MAFbx expression
may be required for proper growth/remodeling of muscle in response to increase loading.
Keywords: ubiquitin proteasome system, protein degradation, puromycin, functional overload, forkhead
transcription factors
INTRODUCTION
Skeletal muscle is a highly plastic tissue that modifies its size
through the regulation of signaling pathways that control pro-
tein synthesis and protein degradation. In response to increases
in mechanical loading, muscle hypertrophy, or an increase in
muscle size, occurs as the result of a net increase in protein syn-
thesis relative to degradation. It has been well demonstrated that
the Akt/mTOR signaling pathway is a major regulator of muscle
growth, as activation of S6K1, eIF4E, and eIF2B stimulate mRNA
translation and ultimately lead to increases in protein synthesis
(Bodine et al., 2001b; Rommel et al., 2001; Kubica et al., 2008).
In addition, recent work has revealed that both beta adrenergic
signaling (Minetti et al., 2011) and bone morphogenetic protein
(BMP) signaling (Sartori et al., 2013) can regulate muscle mass
and promote skeletal muscle hypertrophy. What is less under-
stood is the role of protein degradation in the remodeling process
that occurs in response to loading and leads to an increase in fiber
cross-sectional area.
Increases in protein degradation are generally associated with
the loss of muscle mass, i.e., atrophy, and occur in response to
decreased loading, inactivity, and a variety of pathological condi-
tions. In skeletal muscle, the ubiquitin proteasome system (UPS)
is responsible for the majority of protein degradation (Rock et al.,
1994), although cathepsins, calpains, caspase-3, and autophagy
are also involved in the breakdown of muscle proteins (Du et al.,
2004; Tisdale, 2005). Associated with muscle atrophy and the
increase in protein degradation is the rapid and sustained increase
in MuRF1 and MAFbx/atrogin-1 expression, two muscle-specific
E3 ubiquitin ligases thought to target specific proteins for degra-
dation by the 26S proteasome (Bodine et al., 2001a). Deletion of
MuRF1 orMAFbx has been shown to spare muscle mass in a vari-
ety of atrophy-inducing conditions (Bodine et al., 2001a; Labeit
et al., 2010; Baehr et al., 2011), however, the role of MuRF1 and
MAFbx, as well as the UPS, in regulating increases in muscle fiber
size is less clear.
A few studies have reported increases in MuRF1 and MAFbx
expression following an acute bout of resistance exercise in
humans, however, no studies have made concurrent measure-
ments of protein synthesis and UPS activity following chronic
mechanical loading (Yang et al., 2006; Louis et al., 2007;
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Marino et al., 2008). Thus, the aim of this study was to exam-
ine both protein synthesis and proteasome activity, along with
MuRF1 and MAFbx expression in mice over 14 days of chronic
loading using the functional overload (FO) model. Furthermore,
although we have recently shown that muscle growth is not
impaired in young or old MuRF1 KO mice (Hwee et al., 2013),
it remains to be seen whether growth is affected by the loss of
MAFbx, and whether the loss of MuRF1 or MAFbx depresses
proteasome activity under anabolic conditions.
MATERIALS AND METHODS
ANIMALS
Forty three month old male C57BL/6 wild type (WT) mice and
110 9 month old male and female MuRF1 and MAFbx null (KO)
mice were used for this study. The WTmice were purchased from
Jackson Laboratories and the MuRF1 (n = 60) and MAFbx (n =
50) null mice were generated from a breeding colony maintained
by the UCD Mouse Biology Program in a mouse barrier facility.
To induce hypertrophy of the plantaris muscle, mice were sub-
jected to bilateral functional overload. Mice were anaesthetized
with 2–3% inhaled isoflurane and using aseptic technique, the
ankle extensormuscles and Achilles tendon were exposed bymak-
ing a small incision to the posterior lower limb. The entire soleus
and over half of the medial and lateral gastrocnemius muscles
were removed from each hindlimb without damaging the plan-
taris neural-vascular supply. The wound was irrigated with sterile
saline and the incision was closed with subcuticular sutures. Mice
were given an analgesic (buprenorphine, 0.1mg/kg) immedi-
ately following the surgery and returned to their cage once they
recovered.
At 1, 3, 7, and 14 days post-surgery, the WT animals were
anesthetized with 2–3% inhaled isoflurane and the plantaris mus-
cles were removed, weighed, frozen in liquid nitrogen, and stored
at −80◦C for future analysis. For the MuRF1 and MAFbx KO
mice, the plantaris muscles were removed and weighed following
14 days of FO. The right plantaris muscle was pinned on cork at a
length approximating Lo and frozen in isopentane cooled in liq-
uid nitrogen for histological analysis while the left plantaris mus-
cle was frozen in liquid nitrogen and stored at—80◦C. Following
tissues collection, the mice were euthanized by exsanguination.
All animal procedures were approved by the Institutional Animal
Care and Use Committee at the University of California, Davis.
PROTEIN SYNTHESIS MEASUREMENTS
Protein synthesis was measured in vivo in the WT mice using
the SUnSET method as previously described (Goodman et al.,
2011b). Exactly 30min before the plantaris muscles were excised,
mice were given an intraperitoneal injection of 0.04μmol/g
puromycin dissolved in 100μl of phosphate buffered saline (PBS)
(n = 5/group). Puromycin expression was analyzed by Western
Blot as described below.
mRNA EXPRESSION ANALYSIS
Total RNA was extracted from powdered plantaris muscle using
TRIzol reagent according to the manufacturer’s instructions
(Invitrogen). cDNA was then synthesized using a QuantiTech
Reverse Transcription Kit (Qiagen) from one μg of total RNA.
MuRF1 and MAFbx gene expression was measured by quan-
titative PCR (qPCR) in WT mice following 1, 3, 7, and 14
days of FO (n = 7/group). qPCR was performed using Power
SYBR® Green PCR Master Mix (Life Technologies) on an ABI
7900HT thermocycler. Cycling conditions were one cycle at
94◦C for 10min followed by forty cycles at 94◦C for 30 s,
59◦C for 30 s, and 72◦C for 30 s. Each sample was run
in triplicate. Sequences of the mouse forward and reverse
primers are as follows: MuRF1 forward: 5′-GCTGGTGGAAAA
CATCATTGACAT-3′; reverse: 5′-CATCGGGTGGCTGCCTTT-
3′; MAFbx forward: 5′-CTTTCAACAGACTGGACTTCTCGA-
3′; reverse: 5′-CAGCTCCAACAGCCTTACTACGT-3′; FOXO1
forward: 5′-TTCCTTCATTCTGCACACGA-3′; reverse: 5′-GTC
CTACGCCGACCTCATC-3′; FOXO3a forward: 5′-CAGGCTCCT
CACTGTATTCAGCTA-3′; reverse: 5′-CATTGAACATGTCCAG
GTCCAA-3′; GAPDH forward: 5′- CCAGCCTCGTCCCGTAG
AC-3′; reverse: 5′- ATGGCAACAATCTCCACTTTGC-3′. All data
was normalized to GAPDH expression.
PROTEASOME ACTIVITY
20S and 26S β5 proteasome activity was measured as previously
described (Gomes et al., 2012). Briefly, proteasomes were col-
lected in the supernatant after 30min centrifugation at 12,000 g
following homogenization in 300μl of buffer containing 50mM
Tris, 150mMNaCl, 5mMMgCl2, 1mMEDTA, and 0.5mMDTT
at pH 7.5. The chymotrypsin (β5)-like activities were assayed
using 10μg of protein and the fluorescently tagged substrate
SUC-LLVY-AMC (Bachem). Both assays were carried out in a
total volume of 100μl. The 26S ATP-dependent assay was per-
formed in homogenization buffer with the addition of 100μM
ATP. The 20S ATP-independent assay was carried out in assay
buffer containing 25mM HEPES, 0.5mM EDTA, and 0.001%
SDS (pH 7.5). Each assay was conducted in the absence and
presence of the proteasome inhibitor Bortezomib at a final con-
centration of 2mM. The activity of the 20S and 26S proteasome
was measured by calculating the difference between fluorescence
units recorded with or without the inhibitor in the reaction
medium. Released AMCwas measured using a Fluoroskan Ascent
fluorometer (Thermo Electron) at an excitation wavelength of
390 nm and an emission wavelength of 460 nm. Fluorescence was
measured at 15-min intervals for 2 h. All assays were linear in this
range and each sample was assayed in triplicate.
WESTERN BLOTTING
Frozen plantaris muscles from control and FOmice were homog-
enized in proteasome assay lysis buffer (50mM Tris, 150mM
NaCl, 5mM MgCl2, 1mM EDTA, and 0.5mM DTT at pH 7.5).
The supernatant was collected following centrifugation at 12,000
g for 30min and protein concentrations were determined in
triplicate using the Bradford method (Bio-Rad). Ten to twenty
micrograms of protein was subjected to SDS-PAGE on 10% acry-
lamide gels and transferred to polyvinylidene diflouride (PVDF)
membrane. Membranes were blocked in 3% nonfat dairy milk in
Tris-buffered saline with 0.1% Tween-20 added (TBST) or 1%
pigskin gelatin for 1 h and then probed with primary antibody
overnight at 4◦C. Puromycin (Millipore), BiP (BD Biosciences),
PDI (Cell Signaling), and CHOP (Cell Signaling) were used
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at a concentration of 1:1000. The next day, membranes were
washed and incubated with HRP conjugated secondary antibod-
ies at 1:10,000 for 1 h at room temperature. Immobilon Western
Chemiluminescent HRP substrate (Millipore) was then added to
the membranes. Image acquisition and band quantification was
performed using the ChemiDoc™ MP System and Image Lab 5.0
software (Biorad).
STATISTICS
Results are presented as mean ± standard deviation (SD) unless
otherwise indicated. The data was analyzed by One-Way ANOVA
FIGURE 1 | Time course of load-induced growth in wild type (WT) mice
following functional overload (FO). Growth of the plantaris muscle was
calculated after 1, 3, 7, and 14 days of FO and expressed as a change in
mass relative to the control group. Data are expressed as mean ± SD
(n = 8/group). ∗P < 0.05 vs. control.
or by Student’s t-test (Sigma Stat). Tukey’s post-hoc analysis
was used to determine differences when interactions existed.
Statistical significance was set at p < 0.05.
RESULTS
To determine the extent to which the ubiquitin proteasome sys-
tem (UPS) is activated during a model of load-induced muscle
growth, male C57BL/6 mice were subjected to bilateral functional
overload for 1, 3, 7, or 14 days. As shown in Figure 1, the response
of the plantaris to an increase in load was a swift and steady
increase in size over 14 days. Significant increases in mass of 43
and 65% were observed after 7 and 14 days, respectively.
Given the significant hypertrophy of the plantaris muscle,
we next looked at changes in protein synthesis in the plantaris
muscle over a 14-day period of FO. Protein synthesis was mea-
sured in vivo using the SUrface SEnsing of Translation (SUnSET)
method, a nonradioactive technique in which changes in the rate
of protein synthesis are reflected by the amount of puromycin that
is incorporated into newly synthesized proteins (Schmidt et al.,
2009; Goodman et al., 2011b). Using this method, we found that
protein synthesis increased by 58% at 3 days and was significantly
elevated from 7 to 14 days of FO, reaching a level that was 100%
above control within the first 14 days of FO (Figure 2).
Increases in ER stress can occur during high rates of protein
synthesis (Rayavarapu et al., 2012). Considering that FO produces
significant muscle hypertrophy, we investigated the expression of
various ER stress markers in the plantaris muscle following FO. As
shown in Figure 3, we found significant increases in BiP and PDI
expression beginning at 3 days post FO, with the largest increase
seen after 7 days of FO. The maladaptive ER stress marker CHOP
was also found to increase over the 14 days following FO, however,
the relative increase was significantly lower than that observed for
BiP and PDI (Figure 3B).
FIGURE 2 | Measurement of protein synthesis using the SUnSET
method following functional overload (FO). (A) Representative image of
western blot analysis for puromycin following no treatment (Con) and FO for
1, 3, 7, or 14 days in WT mice. The corresponding ponceau stain was used to
verify equal loading of proteins. (B) Quantification of the puromycin western
blots. Puromycin values are expressed as a percentage of the control
muscles value (mean ± SD, n = 5/group). ∗P < 0.05 vs. control puromycin
expression.
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FIGURE 3 | Markers of endoplasmic reticulum (ER) stress are higher in
the plantaris muscle following functional overload (FO). (A)
Representative western blot of ER stress markers BiP, PDI, and CHOP in
WT mice after no treatment (Con) and 1, 3, 7, and 14 days of FO. (B)
Quantification of the western blots for BiP (open bars), PDI (gray bars), and
CHOP (black bars). A ponceau stain of the membrane was used to
normalize protein expression. Data are expressed as a percentage of the
respective control value for each protein (mean ± SD, n = 4–6/group).
∗P < 0.05 vs. control expression for each protein, #P < 0.05 CHOP vs. BiP,
or PDI at given time point.
In humans, resistance exercise has been shown to increase
protein degradation (Phillips et al., 1997), but it is unclear
whether this breakdown is related to upregulation of MuRF1
and MAFbx expression or alterations in proteasome activity.
Thus, we measured the time course of MuRF1 and MAFbx
expression and the chymotrypsin-like (β5) proteasome activi-
ties in WT mice following FO. In addition, the time course of
FOXO1 and FOXO3a expression was measured since they are
known transcriptional regulators of MuRF1 and MAFbx under
atrophy conditions (Sandri et al., 2004; Waddell et al., 2008).
Expression of both MuRF1 and MAFbx was found to increase
significantly after one day of FO, but then return to control lev-
els by 3 days post FO (Figures 4A,B). After 3 days of FO, gene
expression was suppressed below control levels, with significant
reductions in MAFbx expression occurring after 7 and 14 days
of FO (Figure 4B). The rapid increase in MuRF1 and MAFbx
expression was mirrored by significant increases in 20S and 26S
β5 proteasome activity after 1 day of FO, but unlike MuRF1 and
MAFbx, proteasome activity remained elevated throughout the
14 days of chronic loading (Figures 4D,E). Peak activity for the
20S proteasome was found to occur at 3 days post FO, while
peak activity for the 26S proteasome was found at 7 days post
FO. Surprisingly, the pattern of FOXO1 and FOXO3a expression
was more similar to that of the 26S β5 proteasome rather than
MuRF1 and MAFbx expression. Significant increases in FOXO1
and FOXO3a expression did not occur until 3 days post FO, after
which expression of both genes continued to increase through 7
days of FO before returning to baseline levels at 14 days post FO
(Figure 4C).
Given the changes in MuRF1 and MAFbx expression and pro-
teasome activity following functional overload, we then asked
if deletion of MuRF1 or MAFbx compromised muscle growth.
Fourteen days of overload produced significant growth of the
plantaris in both female and male MuRF1 KO mice, which was
similar to that observed in WT mice of both genders (Figure 5).
This result is comparable to what has been previously reported
for male MuRF1 KO mice (Hwee et al., 2013). In contrast, the
deletion of MAFbx appeared to have a significant effect on load-
induced growth, especially in female mice (Figure 5). In response
to overload, a significant increase in plantaris mass was measured
in male MAFbx KO mice, with the mean increase in mass being
slightly less and more variable in the MAFbx KO (range of mass:
20–34mg) compared to the WT (range of mass: 29–37mg) mice.
In female mice, however, MAFbx KO mice showed no significant
growth in response to FO, which differed significantly from what
was observed in the WT mice (Figure 5).
The decrease in muscle growth did not appear to be due to an
inability to activate the proteasome, as both MuRF1 and MAFbx
KO mice had similar increases in 26S β5 proteasome activity fol-
lowing 14 days of FO (Figure 6). Since we did not have sufficient
numbers of KO mice to collect FO data at 3 and 7 days, we do
not know whether proteasome activity in the KO mice increased
to the same extent as the WT mice.
DISCUSSION
Proteolysis is essential for normal muscle function and routine
protein turnover. Most cellular proteins are degraded by the UPS
(Rock et al., 1994; Mitch and Goldberg, 1996), a highly selective
system that targets proteins for breakdown via the addition of a
polyubiquitin chain. The coordinated effort of three groups of
enzymes, termed E1, E2, and E3s, results in the attachment of
ubiquitin to a substrate protein, with multiple lysine 48-linked
ubiquitin molecules serving as a signal for that protein to be
degraded by the 26S proteasome (Chau et al., 1989). BothMuRF1
and MAFbx have been identified as muscle-specific E3 ubiqui-
tin ligases, making them responsible for catalyzing the transfer of
ubiquitin from the E2 enzyme to the substrate protein. In skeletal
muscle, increases in proteasome activity are generally associated
with muscle atrophy, a process that is characterized by the induc-
tion of MuRF1 and MAFbx (Auclair et al., 1997; Hobler et al.,
1999; Bodine et al., 2001a; Gomes et al., 2001). However, little
is known about the role of the UPS during muscle growth and
whether MuRF1 and/or MAFbx are required for muscle hyper-
trophy. Thus, the purpose of this study was to examine the time
course of MuRF1 and MAFbx expression along with proteasome
activity in a model of load-induced muscle growth, and to deter-
mine if MuRF1 and MAFbx KO mice show an attenuated growth
response following 14 days of functional overload (FO).
Functional overload is a commonly used model for studying
muscle growth in rodents and results in rapid and robust increases
in muscle mass as a result of chronic overload. Hypertrophy in
this model is marked by significant increases in protein synthesis,
which we confirmed in this study using the puromycin technique
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FIGURE 4 | Functional overload (FO) induces a proteolytic response in
the plantaris muscle. mRNA expression of (A) MuRF1, (B) MAFbx, and (C)
FOXO1, and FOXO3a was measured in WT mice following no treatment
(Con) and FO for 1, 3, 7, or 14 days. Expression values were normalized to
GAPDH and are expressed as a fold change (mean ± SD) relative to control
(n = 7/group) ∗P < 0.05 vs. control mRNA expression. Activity of the β5
subunit of the 20S (D) and 26S (E) proteasome was assessed by fluorometric
assay in WT mice following no treatment (Con) and FO for 1, 3, 7, or 14 days.
Data is expressed as a percentage of the control value (mean ± SD,
n = 5–8/group). ∗P < 0.05 vs. control proteolytic activity.
FIGURE 5 | Response of MuRF1 and MAFbx KO mice to functional
overload (FO). Growth of the plantaris muscle was calculated after 14
days of FO in male and female WT, MuRF1 KO, and MAFbx KO mice
and expressed as absolute wet weight (mg). Measurements were made
in untreated control [white (WT) or blue hatched (KO) bars] and
overloaded [black (WT) and blue (KO) bars] muscles. Data are expressed
as mean ± s.e.m and group size is indicated in each bar. ∗P < 0.05 vs.
control; #P < 0.05 vs. WT FO.
(Schmidt et al., 2009; Goodman et al., 2011b). Moreover, the
increase in protein synthesis was closely matched to the increase
in plantaris mass in the WT mice. During this period of ele-
vated protein synthesis, significant increases in the expression
of the ER chaperone proteins BiP and PDI were also observed.
An increase in BiP and PDI expression might be predicted, as
an elevated rate of protein synthesis would increase the protein
handling responsibilities of the endoplasmic reticulum (ER). An
increase in BiP and PDI enhances the protein folding capabili-
ties of the ER (Rayavarapu et al., 2012) and would help reduce
www.frontiersin.org February 2014 | Volume 5 | Article 69 | 5
Baehr et al. Proteasome activity and muscle hypertrophy
FIGURE 6 | Proteasome activity increases in MuRF1 and MAFbx null
(KO) mice after 14 days of functional overload (FO). Proteolytic
activity of the β5 subunit of the 20S (A) and 26S (B) proteasome
was assessed by fluorometric assay in MuRF1 and MAFbx KO mice
after no treatment (Con, open bars) or 14 days of functional overload
(14d FO, black bars). Data are expressed as a percentage of each
respective control value (mean ± SD, n = 4–6/group). ∗P < 0.05 vs.
control.
the number of misfolded proteins and keep ER stress at a mini-
mum. An accumulation of misfolded proteins can cause the ER
to activate apoptosis signaling through an increase in the expres-
sion of CHOP (Fu et al., 2008). Although FO did result in an
increase in CHOP expression, the relative increase in expression
was significantly lower than the increase in BiP and PDI expres-
sion, suggesting that the ER was able to implement an adaptive
response to the influx of newly synthesized proteins, which ulti-
mately get incorporated into the myofibers resulting in increases
in myofiber cross-sectional area and force capacity.
A novel finding in this study was that both 20S and 26S β5 pro-
teasome activity was increased throughout the 14 day overload
period, indicating that increased loading can result in the activa-
tion of machinery involved in protein breakdown. The increase in
proteasome activity occurred within the first 24 h of overload and
increased to a level (4–6-fold) that was much greater than what
we have observed during denervation-induced atrophy (<2-fold)
(Gomes et al., 2012). Interestingly, the peak in 26S β5 activity
occurred at 7 days, a time when protein synthesis was found to
be significantly elevated. This finding is similar to a study by
Miyazaki et al. in which protein synthesis and protein degrada-
tion rates were both found to peak at 7 days after FO (Miyazaki
et al., 2011). However, it is important to note that the largest gains
in muscle mass occurred between 7 and 14 days post FO, which
was the time period in which protein synthesis rates were rising
and proteasome activity was beginning to decrease.
An increase in MuRF1 and MAFbx expression is generally
assumed to lead to an increase in proteasome activity, as a greater
quantity of ubiquitin ligases should increase the number of polyu-
biquitinated proteins inside the cell. However, we show here that
under growth conditions, proteasome activity remained elevated
for a much longer time period than did the induction of MuRF1
and MAFbx. In fact, significant increases in MuRF1 and MAFbx
expression were measured only at day one of FO, and by day 3 of
FO, their expression had returned to baseline levels and then were
suppressed below baseline levels. Our finding that MuRF1 expres-
sion is only increased at 1 day post FO differs slightly from a study
by Marino et al., in which MuRF1 was found to be increased after
3 days of FO (Marino et al., 2008). However, similar results were
found when comparing MAFbx expression, as we also found no
induction of MAFbx at 3 days after FO followed by a significant
decrease in MAFbx expression at 7 and 14 days (Marino et al.,
2008). In the majority of human studies that examined prote-
olytic activity after an acute bout of resistance exercise, MuRF1,
but not MAFbx expression has been shown to increase transiently
after the exercise bout (Yang et al., 2006; Louis et al., 2007;Murton
et al., 2008). However, chronic resistance training in rats resulted
in decreasedMuRF1 andMAFbx expression, whichmay be in line
with this decreased expression we saw at 7 and 14 days following
FO (Zanchi et al., 2009).
Our data show that MuRF1 and MAFbx are not always good
markers of proteasome activity. The apparent disconnect between
MuRF1 and MAFbx expression and proteasome activity has been
previously observed. In a study by Vary et al., acute alcohol intox-
ication increased MuRF1 and MAFbx expression, but did not
increase skeletal muscle proteolysis (Vary et al., 2008). Similarly,
we have shown that 14 days of glucocorticoid treatment did not
result in an increase in activity for any of the three catalytic
subunits of the proteasome despite significant upregulation of
MuRF1 and MAFbx expression (Baehr et al., 2011). Conversely,
when mice were allowed to recover following 7 days of hindlimb
unloading, MuRF1 and MAFbx expression was not increased at
any of the time points analyzed, but 20S β5 proteasome activity
was significantly increased on the first day of recovery (Lang et al.,
2012). Lastly, under denervation conditions, the lack of MuRF1
resulted in greater activation of the proteasome, not less (Gomes
et al., 2012).
Under atrophy conditions, the FOXOs are often implicated in
the induction of MuRF1 and MAFbx, but our results clearly indi-
cate that this is not the case in the functional overload model, as
FOXO expression did not increase until after MuRF1 and MAFbx
expression had returned to baseline levels. The largest increase
in FOXO1 and FOXO3a expression was found to occur after 7
days of functional overload, which is consistent with the findings
of Goodman et al. (2011a) who showed that both total protein
and phosphorylation levels of FOXO1 and FOXO3a were signifi-
cantly elevated at 7 days of FO. Our results suggest that the FOXOs
may be mediating protein degradation independently of MuRF1
and MAFbx, and may be at least partially responsible for the
observed increase in proteasome activity. More work is needed
to determine the role of the FOXOs in regulating the ubiquitin
proteasome system during skeletal muscle growth.
Mechanical loading has been shown to initiate an inflamma-
tory response and a number of cytokines have been reported
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to increase during muscle hypertrophy (Huey et al., 2007). One
cytokine in particular that was reported to be elevated early after
FO was TNFα (Huey et al., 2007). Circulating levels of TNFα can
lead to increases in both MuRF1 and MAFbx expression (Li et al.,
2005; Adams et al., 2008), so it is possible that the short-lived
increase in expression seen in this study was directly related to
muscle inflammation. While an inflammatory response appears
to be required for normal growth following FO (Marino et al.,
2008), it is unclear whether induction of MuRF1 and MAFbx is
critical in this response. Our results indicate that MAFbx, but not
MuRF1, may be necessary for normal remodeling and growth, as
the MAFbx KO mice had an attenuated growth response (espe-
cially among the female animals), whereas the MuRF1 KO mice
showed no deficiencies in their ability to hypertrophy.
In skeletal muscle, a few targets of MAFbx have been identi-
fied, including eIF3f (Lagirand-Cantaloube et al., 2008), MyoD
(Tintignac et al., 2005), and myogenin (Jogo et al., 2009). These
targets are generally associated with protein synthesis (eIF3f),
satellite cell proliferation (MyoD), and muscle-specific gene tran-
scription (MyoD, myogenin), all of which are important for
muscle hypertrophy (Ishido et al., 2004; Baar et al., 2006). In addi-
tion, recent in vitro work by Lokireddy et al. revealed that MAFbx
preferentially degrades sarcomeric proteins following myostatin
treatment, with myosin heavy chain, myosin light chain, desmin,
and vimentin identified as targets of MAFbx ubiquitination
(Lokireddy et al., 2011a,b). Thus, even though it appears that the
lack of MAFbx should promote muscle growth, the inability to
turnover key sarcomeric proteins, such as myosin heavy chain,
during the remodeling process could explain why the growth
response was impaired in the MAFbx KO mice. Furthermore,
while MAFbx KO mice have been shown to spare muscle mass
following denervation (Bodine et al., 2001a), histological anal-
ysis of denervated MAFbx muscles has revealed dystrophic and
necrotic fibers. Consequently, it appears that MAFbx may be
required for the proper remodeling of muscle fibers under growth
and atrophy conditions. The explanation for the finding that the
loss of MAFbx had a greater effect on load-induced growth in
female vs. male mice is not clearly evident. In previous experi-
ments that have examined the response of MAFbx KO mice to
triggers of muscle atrophy, we have observed no gender-based
differences.
Similar to MAFbx, MuRF1 has been reported to interact and
ubiquitinate myofibrillar proteins (Cohen et al., 2009), suggest-
ing that MuRF1 also plays a role in regulating protein turnover.
However, given the normal hypertrophic response to FO in the
MuRF1 KO mice, it seems that MuRF1 is not essential for muscle
growth. Considering that protein synthesis is higher in MuRF1
KO mice under atrophy conditions (Koyama et al., 2008; Baehr
et al., 2011), it may be that the major role of MuRF1 in skeletal
muscle is to suppress protein synthesis. Thus, deletion of MuRF1
is advantageous to muscle growth and consequently, the MuRF1
KO mice maintain an ability to hypertrophy throughout their
lifetime. The different phenotypes in the MuRF1 and MAFbx
KO mice suggest that the two E3 ligases have different physio-
logical substrates. Clearly more research is needed to determine
the physiological targets of both MuRF1 and MAFbx in skeletal
muscle.
In summary, our results indicate that muscle hypertrophy is
associated with increases in both protein synthesis and degra-
dation. The increase in degradation is the result of activation
of the UPS, and proteasome activity remains elevated even after
MuRF1 and MAFbx expression has returned to baseline levels.
Interestingly, MuRF1 and MAFbx expression become suppressed
below baseline even though FOXO1 and FOXO3a expression are
elevated. The loss of MuRF1 or MAFbx does not appear to sup-
press the increase in proteasome activity in response to chronic
increases in load; however, the loss of MAFbx does appear to neg-
atively impact the remodeling process that occurs during growth.
These findings highlight the need for a better understanding of
the roles of MuRF1 andMAFbx in the function of skeletal muscle,
which will require identification of their in vivo substrates.
REFERENCES
Adams, V., Mangner, N., Gasch, A., Krohne, C., Gielen, S., Hirner, S., et al. (2008).
Induction of MuRF1 is essential for TNF-alpha-induced loss of muscle function
in mice. J. Mol. Biol. 384, 48–59. doi: 10.1016/j.jmb.2008.08.087
Auclair, D., Garrel, D. R., Chaouki Zerouala, A., and Ferland, L. H. (1997).
Activation of the ubiquitin pathway in rat skeletal muscle by catabolic doses
of glucocorticoids. Am. J. Physiol. 272, C1007–C1016.
Baar, K., Nader, G., and Bodine, S. (2006). Resistance exercise, muscle load-
ing/unloading and the control of muscle mass. Essays Biochem. 42, 61–74. doi:
10.1042/bse0420061
Baehr, L. M., Furlow, J. D., and Bodine, S. C. (2011). Muscle sparing in muscle
RING finger 1 null mice: response to synthetic glucocorticoids. J. Physiol. 589,
4759–4776. doi: 10.1113/jphysiol.2011.212845
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., et al.
(2001a). Identification of ubiquitin ligases required for skeletal muscle atrophy.
Science 294, 1704–1708. doi: 10.1126/science.1065874
Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein,
R., et al. (2001b). Akt/mTOR pathway is a crucial regulator of skeletal mus-
cle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol. 3,
1014–1019. doi: 10.1038/ncb1101-1014
Chau, V., Tobias, J. W., Bachmair, A., Marriott, D., Ecker, D. J., Gonda, D. K., et al.
(1989). A multiubiquitin chain is confined to specific lysine in a targeted short-
lived protein. Science 243, 1576–1583. doi: 10.1126/science.2538923
Cohen, S., Brault, J. J., Gygi, S. P., Glass, D. J., Valenzuela, D. M., Gartner, C., et al.
(2009). During muscle atrophy, thick, but not thin, filament components are
degraded byMuRF1-dependent ubiquitylation. J. Cell Biol. 185, 1083–1095. doi:
10.1083/jcb.200901052
Du, J., Wang, X., Miereles, C., Bailey, J. L., Debigare, R., Zheng, B., et al. (2004).
Activation of caspase-3 is an initial step triggering acceleratedmuscle proteolysis
in catabolic conditions. J. Clin. Invest. 113, 115–123. doi: 10.1172/JCI18330
Fu, H. Y., Minamino, T., Tsukamoto, O., Sawada, T., Asai, M., Kato, H., et al.
(2008). Overexpression of endoplasmic reticulum-resident chaperone attenu-
ates cardiomyocyte death induced by proteasome inhibition. Cardiovasc. Res.
79, 600–610. doi: 10.1093/cvr/cvn128
Gomes, A. V., Waddell, D. S., Siu, R., Stein, M., Dewey, S., Furlow, J. D., et al.
(2012). Upregulation of proteasome activity in muscle RING finger 1-null mice
following denervation. FASEB J. 26, 2986–2999. doi: 10.1096/fj.12-204495
Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A., and Goldberg, A. L. (2001).
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atro-
phy. Proc. Natl. Acad. Sci. U.S.A. 98, 14440–14445. doi: 10.1073/pnas.251541198
Goodman, C. A., Frey, J. W., Mabrey, D. M., Jacobs, B. L., Lincoln, H. C.,
You, J. S., et al. (2011a). The role of skeletal muscle mTOR in the regu-
lation of mechanical load-induced growth. J. Physiol. 589, 5485–5501. doi:
10.1113/jphysiol.2011.218255
Goodman, C. A., Mabrey, D. M., Frey, J. W., Miu, M. H., Schmidt, E. K., Pierre,
P., et al. (2011b). Novel insights into the regulation of skeletal muscle protein
synthesis as revealed by a new nonradioactive in vivo technique. FASEB J. 25,
1028–1039. doi: 10.1096/fj.10-168799
Hobler, S. C., Williams, A., Fischer, D., Wang, J. J., Sun, X., Fischer, J. E., et al.
(1999). Activity and expression of the 20S proteasome are increased in skeletal
muscle during sepsis. Am. J. Physiol. 277, R434–R440.
www.frontiersin.org February 2014 | Volume 5 | Article 69 | 7
Baehr et al. Proteasome activity and muscle hypertrophy
Huey, K. A., Mccall, G. E., Zhong, H., and Roy, R. R. (2007). Modulation of HSP25
and TNF-α during the early stages of functional overload of a rat slow and fast
muscle. J. Appl. Physiol. 102, 2307–2314. doi: 10.1152/japplphysiol.00021.2007
Hwee, D. T., Baehr, L. M., Philp, A., Baar, K., and Bodine, S. C. (2013). Maintenance
of muscle mass and load-induced growth in Muscle RING Finger 1 null mice
with age. Aging Cell. 1, 92–101. doi: 10.1111/acel.12150
Ishido, M., Kami, K., and Masuhara, M. (2004). Localization of MyoD, myogenin
and cell cycle regulatory factors in hypertrophying rat skeletal muscles. Acta
Physiol. Scand. 180, 281–289. doi: 10.1046/j.0001-6772.2003.01238.x
Jogo, M., Shiraishi, S., and Tamura, T. A. (2009). Identification of MAFbx as
a myogenin-engaged F-box protein in SCF ubiquitin ligase. FEBS Lett. 583,
2715–2719. doi: 10.1016/j.febslet.2009.07.033
Koyama, S., Hata, S., Witt, C. C., Ono, Y., Lerche, S., Ojima, K., et al.
(2008). Muscle RING-finger protein-1 (MuRF1) as a connector of muscle
energy metabolism and protein synthesis. J. Mol. Biol. 376, 1224–1236. doi:
10.1016/j.jmb.2007.11.049
Kubica, N., Crispino, J. L., Gallagher, J. W., Kimball, S. R., and Jefferson, L.
S. (2008). Activation of the mammalian target of rapamycin complex 1 is
both necessary and sufficient to stimulate eukaryotic initiation factor 2B[var
epsilon] mRNA translation and protein synthesis. Int. J. Biochem. Cell Biol. 40,
2522–2533. doi: 10.1016/j.biocel.2008.04.010
Labeit, S., Kohl, C. H., Witt, C. C., Labeit, D., Jung, J., and Granzier, H. (2010).
Modulation of muscle atrophy, fatigue and MLC phosphorylation by MuRF1
as indicated by hindlimb suspension studies on MuRF1-KO mice. J. Biomed.
Biotechnol. 2010:693741. doi: 10.1155/2010/693741
Lagirand-Cantaloube, J., Offner, N., Csibi, A., Leibovitch, M. P., Batonnet-Pichon,
S., Tintignac, L. A., et al. (2008). The initiation factor eIF3-f is a major target for
atrogin1/MAFbx function in skeletal muscle atrophy. EMBO J. 27, 1266–1276.
doi: 10.1038/emboj.2008.52
Lang, S. M., Kazi, A. A., Hong-Brown, L., and Lang, C. H. (2012). Delayed
recovery of skeletal muscle mass following hindlimb immobilization in
mTOR heterozygous mice. PLoS ONE 7:e38910. doi: 10.1371/journal.pone.
0038910
Li, Y.-P., Chen, Y., John, J., Moylan, J., Jin, B., Mann, D. L., et al. (2005). TNF-α acts
via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx
in skeletal muscle. FASEB J. 19, 362–370. doi: 10.1096/fj.04-2364com
Lokireddy, S., McFarlane, C., Ge, X., Zhang, H., Sze, S. K., Sharma, M., et al.
(2011a). Myostatin induces degradation of sarcomeric proteins through a
Smad3 signaling mechanism during skeletal muscle wasting. Mol. Endocrinol.
25, 1936–1949. doi: 10.1210/me.2011-1124
Lokireddy, S., Mouly, V., Butler-Browne, G., Gluckman, P. D., Sharma, M.,
Kambadur, R., et al. (2011b). Myostatin promotes the wasting of human
myoblast cultures through promoting ubiquitin-proteasome pathway-mediated
loss of sarcomeric proteins. Am. J. Physiol.Cell Physiol. 301, C1316–C1324. doi:
10.1152/ajpcell.00114.2011
Louis, E., Raue, U., Yang, Y., Jemiolo, B., and Trappe, S. (2007). Time course
of proteolytic, cytokine, and myostatin gene expression after acute exercise in
human skeletal muscle. J. Appl. Physiol. 103, 1744–1751. doi: 10.1152/japplphys-
iol.00679.2007
Marino, J. S., Tausch, B. J., Dearth, C. L., Manacci, M. V., Mcloughlin, T. J., Rakyta,
S. J., et al. (2008). β2-Integrins contribute to skeletal muscle hypertrophy
in mice. Am. J. Physiol. Cell Physiol. 295, C1026–C1036. doi: 10.1152/ajp-
cell.212.2008
Minetti, G. C., Feige, J. N., Rosenstiel, A., Bombard, F., Meier, V., Werner, A., et al.
(2011). Galphai2 signaling promotes skeletal muscle hypertrophy, myoblast
differentiation, andmuscle regeneration. Sci. Signal. 4, ra80. doi: 10.1126/scisig-
nal.2002038
Mitch, W. E., and Goldberg, A. L. (1996). Mechanisms of muscle wasting. The
role of the ubiquitin-proteasome pathway. N. Engl. J. Med. 335, 1897–1905. doi:
10.1056/NEJM199612193352507
Miyazaki, M., McCarthy, J. J., Fedele, M. J., and Esser, K. A. (2011). Early activa-
tion of mTORC1 signalling in response to mechanical overload is independent
of phosphoinositide 3-kinase/Akt signalling. J. Physiol. 589, 1831–1846. doi:
10.1113/jphysiol.2011.205658
Murton, A. J., Constantin, D., and Greenhaff, P. L. (2008). The involvement
of the ubiquitin proteasome system in human skeletal muscle remodelling
and atrophy. Biochim. Biophys. Acta 1782, 730–743. doi: 10.1016/j.bbadis.2008.
10.011
Phillips, S. M., Tipton, K. D., Aarsland, A., Wolf, S. E., and Wolfe, R. R. (1997).
Mixed muscle protein synthesis and breakdown after resistance exercise in
humans. Am. J. Physiol. 273, E99–E107.
Rayavarapu, S., Coley, W., and Nagaraju, K. (2012). Endoplasmic reticulum stress
in skeletal muscle homeostasis and disease. Curr. Rheumatol. Rep. 14, 238–243.
doi: 10.1007/s11926-012-0247-5
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., et al. (1994).
Inhibitors of the proteasome block the degradation of most cell proteins and the
generation of peptides presented on MHC class I molecules. Cell 78, 761–771.
doi: 10.1016/S0092-8674(94)90462-6
Rommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T.
N., et al. (2001). Mediation of IGF-1-induced skeletal myotube hypertro-
phy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat. Cell Biol. 3,
1009–1013. doi: 10.1038/ncb1101-1009
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., et al. (2004).
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1
and cause skeletal muscle atrophy. Cell 117, 399–412. doi: 10.1016/S0092-
8674(04)00400-3
Sartori, R., Schirwis, E., Blaauw, B., Bortolanza, S., Zhao, J., Enzo, E., et al. (2013).
BMP signaling controls muscle mass. Nat. Genet. 11, 1309–1318. doi: 10.1038/
ng.2772
Schmidt, E. K., Clavarino, G., Ceppi, M., and Pierre, P. (2009). SUnSET, a nonra-
dioactive method to monitor protein synthesis. Nat. Methods 6, 275–277. doi:
10.1038/nmeth.1314
Tintignac, L. A., Lagirand, J., Batonnet, S., Sirri, V., Leibovitch, M. P., and
Leibovitch, S. A. (2005). Degradation of MyoD mediated by the SCF
(MAFbx) ubiquitin ligase. J. Biol. Chem. 280, 2847–2856. doi: 10.1074/jbc.M411
346200
Tisdale, M. J. (2005). The ubiquitin-proteasome pathway as a therapeutic target for
muscle wasting. J. Support. Oncol. 3, 209–217.
Vary, T. C., Frost, R. A., and Lang, C. H. (2008). Acute alcohol intoxication
increases atrogin-1 and MuRF1 mRNA without increasing proteolysis in skele-
tal muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R1777–R1789. doi:
10.1152/ajpregu.00056.2008
Waddell, D. S., Baehr, L. M., Van Den Brandt, J., Johnsen, S. A., Reichardt, H. M.,
Furlow, J. D., et al. (2008). The glucocorticoid receptor and FOXO1 synergisti-
cally activate the skeletal muscle atrophy-associatedMuRF1 gene. Am. J. Physiol.
Endocrinol. Metab. 295, E785–E797. doi: 10.1152/ajpendo.00646.2007
Yang, Y., Jemiolo, B., and Trappe, S. (2006). Proteolytic mRNA expression in
response to acute resistance exercise in human single skeletal muscle fibers.
J. Appl. Physiol. 101, 1442–1450. doi: 10.1152/japplphysiol.00438.2006
Zanchi, N. E., De Siqueira Filho, M. A., Lira, F. S., Rosa, J. C., Yamashita, A.
S., De Oliveira Carvalho, C. R., et al. (2009). Chronic resistance training
decreases MuRF-1 and Atrogin-1 gene expression but does not modify Akt,
GSK-3beta and p70S6K levels in rats. Eur. J. Appl. Physiol. 106, 415–423. doi:
10.1007/s00421-009-1033-6
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 03 December 2013; accepted: 04 February 2014; published online: 21
February 2014.
Citation: Baehr LM, TunziM and Bodine SC (2014) Muscle hypertrophy is associ-
ated with increases in proteasome activity that is independent of MuRF1 and MAFbx
expression. Front. Physiol. 5:69. doi: 10.3389/fphys.2014.00069
This article was submitted to Striated Muscle Physiology, a section of the journal
Frontiers in Physiology.
Copyright © 2014 Baehr, Tunzi and Bodine. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use, dis-
tribution or reproduction in other forums is permitted, provided the original author(s)
or licensor are credited and that the original publication in this journal is cited, in
accordance with accepted academic practice. No use, distribution or reproduction is
permitted which does not comply with these terms.
Frontiers in Physiology | Striated Muscle Physiology February 2014 | Volume 5 | Article 69 | 8
